Cassava Sciences
SAVA
#9322
Rank
NZ$0.15 B
Marketcap
NZ$3.26
Share price
1.55%
Change (1 day)
-22.20%
Change (1 year)

Earnings for Cassava Sciences (SAVA)

Earnings in 2025 (TTM): -NZ$0.2 Billion

According to Cassava Sciences 's latest financial reports the company's current earnings are N/A. In 2024 the company made an earning of -NZ$0.24 Billion a decrease over its 2023 earnings that were of -NZ$0.18 Billion. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Cassava Sciences from 2000 to 2025

Annual earnings

Year Earnings Change
2025 (TTM) -NZ$0.2 Billion-18.49%
2024 -NZ$0.24 Billion34.28%
2023 -NZ$0.18 Billion32.41%
2022 -NZ$0.14 Billion143.46%
2021 -NZ$54.44 Million383.92%
2020 -NZ$11.25 Million36.96%
2019 -NZ$8.22 Million-25.56%
2018 -NZ$11.04 Million-44.25%
2017 -NZ$19.8 Million-20.11%
2016 -NZ$24.78 Million5.32%
2015 -NZ$23.53 Million14.23%
2014 -NZ$20.6 Million-139.64%
2013 NZ$51.94 M
2010 -NZ$22.7 Million102.87%
2009 -NZ$11.19 Million-177.52%
2008 NZ$14.43 M-14.32%
2007 NZ$16.84 M-1942.21%
2006 -NZ$0.92 Million
2004 -NZ$64.54 Million75.1%
2003 -NZ$36.86 Million
2001 -NZ$28.68 Million20.49%
2000 -NZ$23.81 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
ORIC Pharmaceuticals
ORIC
-NZ$0.25 Billion 31.98%๐Ÿ‡บ๐Ÿ‡ธ USA